Microdose Study of Melphalan, Bortezomib and Dexamethasone

NCT02109861 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Melphalan
DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

Henrik Gregersen